1. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study. Issue 11 (November 2021) Authors: Bancroft, Elizabeth K; Page, Elizabeth C; Brook, Mark N; Thomas, Sarah; Taylor, Natalie; Pope, Jennifer; McHugh, Jana; Jones, Ann-Britt; Karlsson, Questa; Merson, Susan; Ong, Kai Ren; Hoffman, Jonathan; Huber, Camilla; Maehle, Lovise; Grindedal, Eli Marie; Stormorken, Astrid; Evans, D Gareth; Rot... Journal: Lancet oncology Issue: Volume 22:Issue 11(2021) Page Start: 1618 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Curious reaction to intrathecal chemotherapy. Issue 1 (22nd December 2018) Authors: Forner, Samantha Lisa; Gough, Jessica; Mikropoulos, Christos Journal: BMJ case reports Issue: Volume 11:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. IMPACT Study: Targeted Prostate Cancer Screening. (29th July 2013) Authors: Mikropoulos, Christos; Eeles, Rosalind A. Journal: Oncologist Issue: Volume 18:Number 8(2013) Page Start: e28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long‐term survival after low‐dose‐rate brachytherapy for prostate cancer: the Royal Surrey experience. (22nd September 2021) Authors: Uribe‐Lewis, Santiago; Uribe, Jennifer; Bourke, Vincent; Deering, Claire; Higgins, Donna; Mehta, Sheel; Mikropoulos, Christos; Otter, Sophie; Perna, Carla; Khaksar, Sara; Laing, Robert; Langley, Stephen Journal: BJU international Issue: Volume 129:Number 6(2022) Page Start: 723 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Low‐Dose‐Rate Prostate Brachytherapy (LDR‐PB) adopts postsurgical PSA value for definition of cure. Issue 1 (19th October 2020) Authors: Uribe, Jennifer; Uribe‐Lewis, Santiago; Khaksar, Sara; Perna, Carla; Mikropoulos, Christos; Otter, Sophie; Laing, Robert; Langley, Stephen Journal: BJUI Compass Issue: Volume 2:Issue 1(2021) Page Start: 9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Low‐Dose‐Rate Prostate Brachytherapy (LDR‐PB) adopts postsurgical PSA value for definition of cure. Issue 1 (19th October 2020) Authors: Uribe, Jennifer; Uribe‐Lewis, Santiago; Khaksar, Sara; Perna, Carla; Mikropoulos, Christos; Otter, Sophie; Laing, Robert; Langley, Stephen Journal: BJUI Compass Issue: Volume 2:Issue 1(2021) Page Start: 9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Psychosocial effects of whole-body MRI screening in adult high-risk pathogenic TP53 mutation carriers: a case-controlled study (SIGNIFY). Issue 4 (12th November 2019) Authors: Bancroft, Elizabeth K; Saya, Sibel; Brown, Emma; Thomas, Sarah; Taylor, Natalie; Rothwell, Jeanette; Pope, Jennifer; Chamberlain, Anthony; Page, Elizabeth; Benafif, Sarah; Hanson, Helen; Dias, Alexander; Mikropoulos, Christos; Izatt, Louise; Side, Lucy; Walker, Lisa; Donaldson, Alan; Cook, Jackie... Journal: Journal of medical genetics Issue: Volume 57:Issue 4(2020) Page Start: 226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Serum testosterone and prostate cancer in men with germline BRCA1/2 pathogenic variants. Issue 3 (9th January 2023) Authors: Dias, Alexander; Brook, Mark N.; Bancroft, Elizabeth K.; Page, Elizabeth C.; Chamberlain, Anthony; Saya, Sibel; Amin, Jan; Mikropoulos, Christos; Taylor, Natalie; Myhill, Kathryn; Thomas, Sarah; Saunders, Edward; Dadaev, Tokhir; Leongamornlert, Daniel; Dyrsø Jensen, Thomas; Evans, D. Gareth; Cybu... Journal: BJUI Compass Issue: Volume 4:Issue 3(2023) Page Start: 361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial. Issue 3 (March 2023) Authors: Brown, Janet E; Royle, Kara-Louise; Gregory, Walter; Ralph, Christy; Maraveyas, Anthony; Din, Omar; Eisen, Timothy; Nathan, Paul; Powles, Tom; Griffiths, Richard; Jones, Robert; Vasudev, Naveen; Wheater, Matthew; Hamid, Abdel; Waddell, Tom; McMenemin, Rhona; Patel, Poulam; Larkin, James; Faust, G... Journal: Lancet oncology Issue: Volume 24:Issue 3(2023) Page Start: 213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening. (15th August 2021) Authors: Benafif, Sarah; Ni Raghallaigh, Holly; McGrowder, Eva; Saunders, Edward J.; Brook, Mark N.; Saya, Sibel; Rageevakumar, Reshma; Wakerell, Sarah; James, Denzil; Chamberlain, Anthony; Taylor, Natalie; Hogben, Matthew; Benton, Barbara; D'Mello, Lucia; Myhill, Kathryn; Mikropoulos, Christos; Bowen‐Per... Journal: BJU international Issue: Volume 129:Number 3(2022) Page Start: 325 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗